The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,809,784 in first-year total cost, median $1,404,892.
Most frequent study sections
- Cellular and Molecular Biology of Neurodegeneration Study Section[CMND]2
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL1
- UT SOUTHWESTERN MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2023 | How Serine-129 Phosphorylation Status Affects the Spreading of α-Synuclein Pathology in Vivo: a Study in Knock-in Animals1RF1NS133979-01 | DETTMER, ULFRAMALINGAM, NAGENDRAN | BRIGHAM AND WOMEN'S HOSPITAL, MA | $2,192,716 | CMND |
| 2023 | Determine the neurotoxicity of RNA metabolism dysfunction caused by cytoplasmic TDP-43 aggregates1R01NS133517-01 | SHAHMORADIAN, SARAH H | UT SOUTHWESTERN MEDICAL CENTER, TX | $617,068 | CMND |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.